Ensysce Biosciences Bolsters Management Team with Regulatory Expert

May 12, 2025 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for abuse and overdose, today announced it has added Tracy Hysong, CCRA as Senior Director of Regulatory Affairs to its management team.Ms. Hysong is a Certified Clinical Research Associate (CCRA) through the Association of Clinical Research Professionals...

Read more

Ainos Reports First Quarter 2025 Financial Results

May 12, 2025 8:00 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company") today announced its financial results for the first quarter ended March 31, 2025.Chun-Hsien (Eddy) Tsai, Chairman of the Board, President, and Chief Executive Officer of Ainos, commented, "Q1 2025 represents a significant step forward in advancing our long-term strategy to build a differentiated healthcare and technology company powered by scent digitization, AI-enhanced...

Read more

Wellgistics Health Reports 36% Revenue Growth in Q1 2025 as Manufacturer Access and Pharmacy Onboarding Accelerate

May 12, 2025 7:40 AM

Wellgistics Health, Inc. (NASDAQ:WGRX, "Wellgistics Health"), a healthcare infrastructure and pharmaceutical distribution company leveraging proprietary technology, today announced financial results for its first fiscal quarter ended March 31, 2025.Revenue for the Q1 2025 quarter increased to $10.86 million from zero during the comparable period last year on a GAAP basis. Had the Company acquired Wood Sage and Wellgistics LLC as of January 1,...

Read more

Has The DEA Declared War on Weed: DEA Is Blocking MMJ Cannabis Medicine Development

May 12, 2025 7:00 AM

While the FDA advances groundbreaking clinical trials for cannabinoid-based treatments targeting Huntington's Disease, Multiple Sclerosis, and other incurable conditions, the Drug Enforcement Administration (DEA) has weaponized its authority to sabotage progress. In an era demanding scientific collaboration, the DEA operates as a rogue entity-prioritizing bureaucratic power over patient lives. MMJ BioPharma Cultivation, the sole company...

Read more

Genflow Biosciences PLC Announces Holding(s) in Company

May 12, 2025 6:30 AM

TR-1: Standard form for notification of major holdingsNOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:Genflow Biosciences1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)Non-UK issuer 2. Reason for the notification (please...

Read more

Race to Erase MS Gala Unveils Star-Studded 32nd Annual Event and Exclusive Silent Auction

May 12, 2025 6:30 AM

Race to Erase MS, in partnership with First Love Productions LLC, is thrilled to announce the 32nd Annual Race to Erase MS Gala and Silent Auction, set for Friday, May 16, 2025, from 6:00 PM to 9:00 PM at the iconic Fairmont Century Plaza in Los Angeles. This premier fundraising event fuels groundbreaking research to eradicate multiple sclerosis through the foundation's innovative Center Without Walls program.This year's Gala promises an...

Read more

Notice to the Annual General Meeting in IRLAB Therapeutics AB

May 12, 2025 2:50 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - IRLAB Therapeutics AB, reg. no. 556931-4692 ("IRLAB" or the "Company"), holds its Annual General Meeting on Wednesday 11 June 2205 at 17:00 (CEST) at MAQS Advokatbyrå's office on Masthamnsgatan 13, Gothenburg, Sweden. Entry and registration begin at 16:00 (CEST).For the full notice and supporting douments, please refer to the Swedish version of this pressrelease or visit Annual General Meeting 2025 -...

Read more

Cantargia Announces Successful Phase 1 Results: PK/PD Data of Subcutaneously Administered CAN10 Confirms Every 4-Week Dosing Choice in Phase 2

May 12, 2025 2:00 AM

Cantargia (STO:CANTA)Pharmacokinetic (PK) model generated based on the single ascending dose (SAD) data and the first multiple ascending dose (MAD) cohort.Model confirms the predicted dosing regimen for phase 2, including subcutaneous (SC) dosing every 4-week.Safety of multiple SC dosing at a clinically relevant dose confirmed.Potent and long-lasting inhibitory effects on several key inflammatory biomarkers.Cantargia (Cantargia AB (publ); Nasdaq...

Read more

Black Book Unveils Q2 2025 Global EHR Market Update: 14 Regional and Multi-National Vendors Take the Lead in Transforming Worldwide Healthcare IT

May 10, 2025 6:00 PM

Black Book™ Market Research has released a Q2 comprehensive update to Global EHR Market Report revealing a growing shift in international healthcare IT dynamics. Drawing on the voices of over 11,000 clinicians, IT leaders, and healthcare operations executives across 44 countries, the Q2 2025 findings underscore the surge of regional and multi-national EHR vendors that are now outpacing U.S.-based giants in client satisfaction, speed of...

Read more

CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025

May 9, 2025 6:30 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the first quarter ended March 31, 2025, after the stock market closes on Wednesday, May 14, 2025. The Company will hold a conference call with the investment community at...

Read more

Veteran ER Physician Dr. Chris Endfinger Featured in Inspiring In-Depth Interview on Life, Medicine, and Leadership

May 9, 2025 3:00 PM

Dr. Chris Endfinger, a respected Emergency Room physician with nearly three decades of frontline medical experience, is the focus of a compelling new online interview. The interview offers a rare and insightful look into the personal and professional journey of one of Alabama's most dedicated medical professionals.With a career spanning 28 years in emergency care, including leadership as the former ER Director at Gadsden Regional Hospital, Dr....

Read more

WellBridge Surgical Recognized with IBJ Fast 25 Award, Capping a Year of Prestigious Honors

May 9, 2025 12:45 PM

WellBridge Surgical, a trailblazer in transparent, affordable outpatient surgical care, has been named to the Indianapolis Business Journal's (IBJ) 2025 Fast 25 list, celebrating Indiana's fastest-growing private companies. This accolade highlights WellBridge's impressive revenue growth and innovative approach to healthcare delivery.​The Fast 25 recognition follows a series of significant honors for WellBridge Surgical. In May 2024, the company...

Read more

Black Book Research Unveils Strategic Innovations to Lead Healthcare IT Market Intelligence in the Age of AI

May 9, 2025 10:00 AM

As artificial intelligence rapidly redefines the boundaries of traditional market intelligence, Black Book Research is advancing a bold new strategy to remain the independent leader in healthcare IT research and client experience surveying free of commercial bias. In a newly released report, Black Book outlines seven transformative trends and internal innovations designed to future-proof its research methodologies, strengthen its commitment to...

Read more

EDGe Surgical Raises Over $1.3M to Accelerate Commercial Expansion and Launch New Ortho EDG SKUs

May 9, 2025 10:00 AM

EDGe Surgical, a medical device company advancing single-use digital instruments for orthopedic and spine surgery, today announced it has raised over $1.3 million in funding to accelerate commercial expansion, restructure debt, and introduce two new SKUs-100mm and 35mm-of its flagship Ortho EDG® device.This capital will support the growth of the sales team, marketing efforts, inventory expansion, and enhanced customer support-positioning EDGe...

Read more

Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET

May 9, 2025 9:25 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, May 15, 2025, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its first quarter ended March 31, 2025. A question-and-answer session will follow management's prepared...

Read more

Protagonist Announces Icotrokinra Phase 3 Data on Difficult-to-Treat Scalp and Genital Psoriasis and Preclinical Data on PN-881 Presented at the Society for Investigative Dermatology Annual Meeting

May 9, 2025 8:05 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced new clinical data from the Phase 3 ICONIC-TOTAL a study investigating icotrokinra, the first-in-class oral peptide antagonist targeting IL-23 receptor and preclinical characterization of PN-881, the first-in-class oral peptide antagonist blocking the three dimeric forms of IL-17 (AA, AF and FF), were presented separately today at the 2025 Society for Investigative...

Read more

Vision Therapy, Reimagined by a Doctor: OTUS AI Training System Now Available in the U.S.

May 9, 2025 8:00 AM

Edenlux Corp., a South Korean AI-powered vision wellness technology developer, is launching its award-winning vision training system OTUS in the U.S. market. OTUS is designed for professional vision therapy settings and brings automation and precision to accommodation training, helping clinics manage more patients more efficiently. Rather than serving as a general consumer device, OTUS is a clinical-grade system that allows vision therapy...

Read more

Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference

May 9, 2025 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be participating in an Analyst-Moderated fireside chat at the 2025 Bank of America Health Care Conference on Wednesday, May 14th, 2025, at 1:40 pm PT. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation.About...

Read more

DEA Thomas Prevoznik Unchecked Authority Obstructing FDA Authorized Marijuana Drug Development

May 9, 2025 5:00 AM

At the heart of the marijuana growing controversy surrounding the DEA lies a critical question: Should one unelected bureaucrat - Deputy Assistant Administrator Thomas Prevoznik - possess the unchecked authority to derail critical scientific breakthroughs in the United States? For seven years, Prevoznik has been responsible in stalling MMJ BioPharma Cultivation's FDA sanctioned efforts to develop cannabis-based pharmaceuticals for diseases like...

Read more

Lancens Technology Selected to Power Next Generation Connected Healthcare Solutions Through the Healthcare Impact Alliance

May 9, 2025 3:00 AM

Lancens Technology, a leading developer of IoT connectivity solutions, today announced its selection as the core technology provider for The Healthcare Impact Alliance's (The HIA) groundbreaking Lifeline Healthwatch platform, which will power Connect America's next-generation connected healthcare devices.Lancens will develop and manufacture the central WiFi 6 controlling module that serves as the foundation of the Lifeline Healthwatch system....

Read more